United States v. Thomas Ukoshovbera A. Gbenedio

95 F.4th 1319
Court of Appeals for the Eleventh Circuit·Decided March 6, 2024·No. 22-12044·Published·Cited by 7 cases

Opinion

[PUBLISH]

In the

United States Court of Appeals For the Eleventh Circuit

No. 22-12044

UNITED STATES OF AMERICA, Plaintiff-Appellee,

versus THOMAS UKOSHOVBERA A. GBENEDIO,

Defendant-Appellant.

Appeal from the United States District Court for the Northern District of Georgia D.C. Docket No. 1:17-cr-00430-TWT-JSA-1

2 Opinion of the Court 22-12044

Before WILLIAM PRYOR, Chief Judge, and ROSENBAUM and ABUDU, Circuit Judges. WILLIAM PRYOR, Chief Judge:

This appeal requires us to decide whether the district court abused its discretion by denying a motion to dismiss an indictment and making certain evidentiary rulings, and whether it clearly erred by imposing a $200,000 fine. A grand jury charged Thomas Ukoshovbera A. Gbenedio, formerly a licensed pharmacist, with 72 counts of unlawful drug dispensing and one count of refusing an inspection of his pharmacy. The indictment charged that he filled prescriptions “outside the course of professional practice and for other than a legitimate medical purpose.” In other words, Gbenedio allegedly operated a “pill mill.” A jury convicted Gbenedio on all but two counts of unlawful drug dispensing. The district court sentenced him to 188 months of imprisonment and ordered him to pay a fine. Because the indictment alleged enough facts to give Gbenedio notice of the charges against him, the district court did not abuse its discretion in its evidentiary rulings, and Gbenedio admitted that he could pay a fine within the guideline range, we af- firm.

I. BACKGROUND

Gbenedio was a licensed pharmacist and the sole proprietor of Better Way Pharmacy, an independent pharmacy in Mableton, Georgia. He managed the day-to-day operations at Better Way, which included dispensing controlled substances and interacting with customers. Federal investigators learned about Better Way

22-12044 Opinion of the Court 3

while investigating other entities, including Express Health, a nearby pain clinic. Investigators determined that from 2013 to 2015, Gbenedio filled nearly 500 fraudulent prescriptions for highly addictive controlled substances such as oxycodone, hydromorphone , and hydrocodone. As a licensed pharmacy, Better Way was subject to inspections by the federal Drug Enforcement Administration . In 2017, agents arrived for an inspection of Better Way, but Gbenedio stood in the way and refused to allow the agents to conduct their inspection. An agent arrested him for obstruction.

A grand jury returned a 71-count indictment against Gbenedio . The indictment charged 70 counts of unlawful drug dispensing , see 21 U.S.C. § 841(a)(1), and one count of refusing an inspection , see id. § 842(a)(6). The indictment charged that Gbenedio filled the prescriptions “outside the course of professional practice and for other than a legitimate medical purpose.” Then, in table format, the indictment listed the specific prescriptions and, for each count, specified the date Gbenedio distributed the controlled substance , the prescription number, the kind and amount of the controlled substance, and the initials of the customer who received it.

In 2018, Gbenedio moved for a bill of particulars. He asked the prosecutors to specify how he acted “outside the course of professional practice and for other than legitimate medical purposes.” The prosecution opposed the motion but informed Gbenedio that “the primary manner” in which it alleged that Gbenedio “illegally dispensed controlled substances involved dispensing pursuant to prescriptions [Gbenedio] knew or should have known were forged

4 Opinion of the Court 22-12044

and/or fraudulent.” Gbenedio then moved to dismiss the unlawful dispensing counts. Although he conceded that his motion was untimely , Gbenedio argued that the indictment was legally insuffi- cient because it failed to provide notice of the “basis for the prosecution ” and “the prosecution’s theory of the case.”

A magistrate judge denied the motion for a bill of particulars . And it recommended that the district court deny the motion to dismiss the indictment because the motion was untimely and the indictment was legally sufficient. The district court adopted the magistrate judge’s recommendation.

One week before trial was scheduled to begin, Gbenedio moved to continue trial. The district court granted the motion and ordered the government to supplement its response to Gbenedio’s motion for a bill of particulars. In its amended response, the government explained that to prove that Gbenedio acted “outside the scope of professional practice” and “without a legitimate medical purpose,” it intended to introduce testimony about a pharmacist’s responsibilities when handling controlled substances and various “red flags” present on the face of the prescriptions that Gbenedio filled.

Gbenedio filed a renewed motion to dismiss the unlawful dispensing counts. The magistrate judge again recommended that the district court deny the motion to dismiss, and the district court adopted that recommendation. Nevertheless, the magistrate judge granted Gbenedio’s motion for a bill of particulars. So the prosecution complied and offered its theory of the case. Consistent with

22-12044 Opinion of the Court 5

its earlier filings, the prosecution explained that it planned to introduce testimony about a pharmacist’s responsibilities when handling controlled substances and various “red flags” on the face of the prescriptions that Gbenedio filled.

A grand jury later charged Gbenedio in a superseding indictment that added two counts of unlawful drug dispensing. The operative indictment charged 72 counts of unlawful drug dispensing (counts 1–72), see id. § 841(a)(1), and one count of refusing an inspection (count 73), see id. § 842(a)(6). Like the earlier indictment, this one charged that the prescriptions were filled “outside the course of professional practice and for other than a legitimate medical purpose.” And for each of the first 72 counts, the indictment specified the date of distribution, the prescription number, the kind and amount of the controlled substance, and the initials of the customer who received it. Gbenedio moved to dismiss the unlawful dispensing counts. The district court adopted the magistrate judge’s recommendation to deny the motion.

In October 2021, Gbenedio proceeded to trial on all counts.

During opening statements, the prosecutor outlined the charges against Gbenedio and previewed the evidence it would present. As expected, the prosecutor asserted that Gbenedio filled “fake and fraudulent” prescriptions. Gbenedio’s counsel previewed the defense and explained that while operating his business, Gbenedio “ran into people who were running their own scheme.” In other words, although Gbenedio filled fake prescriptions, he did so

6 Opinion of the Court 22-12044

because he was misled by bad actors. Gbenedio’s counsel also told the jury that the prosecution would rely on testimony from felons.

During the prosecution’s case-in-chief, witnesses explained the legal obligations of pharmacists. A witness explained that under the Controlled Substances Act, a pharmacist must verify that a prescription was ordered by a doctor acting in the usual course of his practice and for a legitimate medical need. If there is any indication that the prescription might be illegitimate, the pharmacist must inquire further or refuse to fill the prescription. And if the pharmacist dispenses that prescription in the face of unresolved issues , he is as liable as the physician who issued it.

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Thomas Ukoshovbera A. Gbenedio, 95 F.4th 1319 (11th Cir. 2024).

95 F.4th 1319 (United States v. Thomas Ukoshovbera A. Gbenedio) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Richard Colvin
Eleventh Circuit, 2026
United States v. John Melton
Eleventh Circuit, 2026
United States v. Johnnie Lott
Eleventh Circuit, 2025
Ronald Page v. State
Court of Appeals of Georgia, 2024